{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T11:51:52Z","timestamp":1791719512159,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.antiviral.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T14:53:39Z","timestamp":1505919219000},"page":"205-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study"],"prefix":"10.1016","volume":"146","author":[{"given":"Antoine","family":"Rousseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutolleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Titier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9427-7008","authenticated-orcid":false,"given":"Tristan","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chiquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gueudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"M'Garrech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Burrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Agut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Deback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Labetoulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Berrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutolleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Burrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chiquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Deback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gueudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gabison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Hoffart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Labetoulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Muraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Schweitzerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.09.013_bib1","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1128\/JVI.75.7.3105-3110.2001","article-title":"Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues","volume":"75","author":"Bestman-Smith","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-3542(95)00066-6","article-title":"Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy","volume":"28","author":"Beutner","year":"1995","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.09.013_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/exer.2000.0886","article-title":"Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene","volume":"71","author":"Bodaghi","year":"2000","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.antiviral.2017.09.013_bib4","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/AAC.00669-10","article-title":"Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals","volume":"54","author":"Burrel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.09.013_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jviromet.2012.05.031","article-title":"Routine use of duplex real-time PCR assays including a commercial internal control for molecular diagnosis of opportunistic DNA virus infections","volume":"185","author":"Burrel","year":"2012","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.antiviral.2017.09.013_bib6","first-page":"822","article-title":"Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence","volume":"60","author":"Chrisp","year":"1989","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib7","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/jmv.21773","article-title":"Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models","volume":"82","author":"Dambrosi","year":"2010","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/590668","article-title":"Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis","volume":"198","author":"Duan","year":"2008","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.013_bib9","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/606028","article-title":"Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis","volume":"200","author":"Duan","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.013_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","article-title":"Herpes simplex epithelial and stromal keratitis: an epidemiologic update","volume":"57","author":"Farooq","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/AAC.17.2.209","article-title":"Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in\u00a0vitro and in\u00a0vivo","volume":"17","author":"Field","year":"1980","journal-title":"Antimicrob. agents Chemother."},{"key":"10.1016\/j.antiviral.2017.09.013_bib12","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00003226-200310001-00008","article-title":"Quantitative analysis of herpes simplex virus genome in tears from patients with herpetic keratitis","volume":"22","author":"Fukuda","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.antiviral.2017.09.013_bib13","unstructured":"Guideline on bioanalytical method evaluation, (2011)."},{"key":"10.1016\/j.antiviral.2017.09.013_bib14","unstructured":"Harding SP, Rigal D, Easty DL, Sarapa N, Weller S. Superior Intraocular Penetration of Aciclovir from Valaciclovir in Comparison with Oral Aciclovir. 21st International Congress of Chemotherapy (ICC); Birningham1999."},{"key":"10.1016\/j.antiviral.2017.09.013_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM199807303390503","article-title":"Acyclovir for the prevention of recurrent herpes simplex virus eye disease","volume":"339","author":"Herpetic Eye Disease Study Group","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2017.09.013_bib16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archopht.118.8.1030","article-title":"Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis","volume":"118","author":"Herpetic Eye Disease Study Group","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjo.68.3.192","article-title":"Pharmacokinetics of oral acyclovir (Zovirax) in the eye","volume":"68","author":"Hung","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.preteyeres.2006.05.001","article-title":"Herpes simplex keratitis","volume":"25","author":"Kaye","year":"2006","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.antiviral.2017.09.013_bib19","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1167\/iovs.09-3729","article-title":"A\u00a0double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva","volume":"50","author":"Kumar","year":"2009","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2017.09.013_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jfo.2011.10.002","article-title":"Current concepts in the treatment of herpetic keratitis","volume":"35","author":"Labetoulle","year":"2012","journal-title":"J.\u00a0Fr. Ophtalmol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ophtha.2004.11.052","article-title":"Incidence of herpes simplex virus keratitis in France","volume":"112","author":"Labetoulle","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.antiviral.2017.09.013_bib22","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archopht.1989.01070020226030","article-title":"Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982","volume":"107","author":"Liesegang","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib23","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/AAC.47.8.2438-2441.2003","article-title":"Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir","volume":"47","author":"Lycke","year":"2003","journal-title":"Antimicrob. agents Chemother."},{"key":"10.1016\/j.antiviral.2017.09.013_bib24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/dkh244","article-title":"Pharmacokinetics of valaciclovir","volume":"53","author":"MacDougall","year":"2004","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2017.09.013_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ajo.2007.06.001","article-title":"Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study","volume":"144","author":"Miserocchi","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J.\u00a0Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ophtha.2016.10.001","article-title":"Persistent impairment of quality of life in patients with herpes simplex keratitis","volume":"124","author":"Reynaud","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.antiviral.2017.09.013_bib28","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1086\/338046","article-title":"Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir","volume":"33","author":"Sarisky","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.013_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/bjo.2010.191049","article-title":"Evaluation of tear samples for Herpes Simplex Virus 1 (HSV) detection in suspected cases of viral keratitis using PCR assay and conventional laboratory diagnostic tools","volume":"95","author":"Satpathy","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.antiviral.2017.09.013_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/135965350400900413","article-title":"Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients","volume":"9","author":"Stranska","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2017.09.013_bib31","series-title":"R: a Language and Environment for Statistical Computing","author":"Team","year":"2011"},{"key":"10.1016\/j.antiviral.2017.09.013_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.antiviral.2005.11.004","article-title":"Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR","volume":"69","author":"Thi","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.09.013_bib33","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/infdis\/jit350","article-title":"Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis","volume":"208","author":"van Velzen","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.013_bib34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.1993.196","article-title":"Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers","volume":"54","author":"Weller","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.antiviral.2017.09.013_bib35","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/infdis\/jis761","article-title":"Antiviral resistance and the future landscape of hepatitis C virus infection therapy","volume":"207","author":"Wyles","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.013_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.ico.0000240081.19635.db","article-title":"Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation","volume":"26","author":"Zhang","year":"2007","journal-title":"Cornea"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217303881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217303881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T03:10:25Z","timestamp":1659496225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217303881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":36,"alternative-id":["S0166354217303881"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.09.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}